Form 4 for HROW HARROW, INC.
Accepted 2025-04-07 00:00:00 ET · period of report 2025-04-03 · accession 0001641172-25-003111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-07 | 2025-04-07 | HROW | SAHAREK JOHN P. | CEO, Pres, ImprimisRx | F - Tax | $23.09 | -109.5K | 467.4K | -19% | -$2.53M |
| D | 2025-04-07 | 2025-04-03 | HROW | SAHAREK JOHN P. | CEO, Pres, ImprimisRx | M - OptEx | $0.00 | +277.2K | 576.9K | +93% | $0 |
| D | 2025-04-07 | 2025-04-03 | HROW | SAHAREK JOHN P. | CEO, Pres, ImprimisRx | M - OptEx | $0.00 | -277.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-07 | F | D | 109,475 | $23.09 | 467,388 | D | — | — | (F1) The 277,200 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 109,475 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan. |
| 2 | Common | Common Stock | 2025-04-03 | M | A | 277,200 | $0.00 | 576,863 | D | — | — | (F1) The 277,200 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 109,475 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan. |
| 3 | Derivative | Performance Stock Unit | 2025-04-03 | M | D | 277,200 | $0.00 | 0 | D | — · — to — | 277,200 Common Stock | (F1) The 277,200 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 109,475 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan. |